Latest News

Nina Kirmiz wins poster award

January 10, 2016

Congrats to Nina Kirmiz on her poster award achieved during the recent RMI Research Symposium.  Way to go Nina!!

Zach Lewis's Paper on Bifidobacterial Species QC profiled

November 26, 2015

Zach Lewis's paper demonstrating a new method for differentiating B. longum subsp. infantis from B. longum subsp. longum and it's use to test various probiotic label claims is getting some attention from the press.

Liver Cancer-Gut Microbiome work profiled by Synthesis

May 04, 2015

The work by Dr. Yvonne Wan with Dr. Carolyn Slupsky and Dr. Mills to examine the influence of the gut microbiome on the onset liver cancer was recently profiled by the UC Davis Comprehensive Cancer Center magazine Synthesis.   In this work the researchers will test if milk glycans and Bifidobacterium infantis can dampen inflammation and thereby lower incidence of liver cancer.

Dr. Mills Elected Fellow in American Academy of Microbiology

February 25, 2015

Congrats to Dr. Mills for being elected a Fellow in the American Academy of Microbiology.  The Academy recognizes excellence, originality, and leadership in the microbiological sciences, and election to this group is a mark of distinction. Academy Fellows are eminent leaders in the field of microbiology and are relied upon for authoritative advice and insight on critical issues in microbiology.

NIH Grant Success on Milk Bioactives!!

November 26, 2014

Two new NIH grants were recently awarded involving Milk Bioactives group at FFHI.   The first is a $2.7M grant from the National Cancer Institute is led by Yu-Jui Yvonne Wan, a professor and vice chair for research in the Department of Pathology and Laboratory Medicine and also involves Dr. Mills and Dr. Carolyn Slupsky (FST).  The second grant is for $4.2M from the National Center for Complementary and Alternative Medicine is led by Dr. Mills and the FFHI Milk Bioactives Group (Drs.